4//SEC Filing
Wallroth Donald E. 4
Accession 0001209191-09-028868
CIK 0001340752other
Filed
May 25, 8:00 PM ET
Accepted
May 26, 9:41 PM ET
Size
11.0 KB
Accession
0001209191-09-028868
Insider Transaction Report
Form 4
Wallroth Donald E.
Chief Financial Officer
Transactions
- Sale
Common Stock
2009-05-22$3.80/sh−4,000$15,186→ 16,000 total - Sale
Common Stock
2009-05-22$3.75/sh−2,500$9,376→ 13,500 total
Issuer
Molecular Insight Pharmaceuticals, Inc.
CIK 0001340752
Entity typeother
Related Parties
1- filerCIK 0001410709
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 9:41 PM ET
- Size
- 11.0 KB